This week in Other Barks & Bites: Tesla CEO Elon Musk cites worsening U.S. economy in an internal email telling executives that the company’s workforce should be reduced by 10%; Ford Motor Company signs a patent licensing agreement with Avanci after an adverse patent ruling in Munich; the Federal Circuit affirms a jury verdict of willful infringement after dismissing an appeal challenging the district court’s judicial correction of a claim term; the U.S. Patent and Trademark Office announces that it has established a pilot program to prioritize examination of climate change patent applications; the Ninth Circuit remands a trademark cancellation claim to the district court after finding an improper application of Star-Kist’s precedent on standing; and Advocate General Szpunar tells the Court of Justice of the European Union that Amazon has not made a use of Louboutin trademarks under the meaning of EU law by listing offers for sale by third-parties offering counterfeit Louboutin footwear.
Patent
- Enablement
- Fee Shifting
- Litigation
- Other Barks & Bites for Friday, March 31: Japan Restricts Chip-Making Exports, Ocado Scores UK High Court Win in Robotic Warehousing Case, and Judge Rejects Fair Use Defense for Internet Archive
- U.S. Government Sides with Teva in Skinny Label SCOTUS Fight
- Industry, NGOs Spar Over Need to Extend TRIPS COVID IP Waiver at ITC Hearing
- Software-Related U.S. Patent Grants in 2022 Remained Steady While Chinese Software Patents Rose 8%
- The Truth Leaks Out: Justices Struggle with the Science, Sanofi Welcomes End to Functional Genus Claims in Amgen Oral Arguments
Recent Posts
- Other Barks & Bites for Friday, March 31: Japan Restricts Chip-Making Exports, Ocado Scores UK High Court Win in Robotic Warehousing Case, and Judge Rejects Fair Use Defense for Internet Archive
- U.S. Government Sides with Teva in Skinny Label SCOTUS Fight
- Industry, NGOs Spar Over Need to Extend TRIPS COVID IP Waiver at ITC Hearing
- Software-Related U.S. Patent Grants in 2022 Remained Steady While Chinese Software Patents Rose 8%
- The Truth Leaks Out: Justices Struggle with the Science, Sanofi Welcomes End to Functional Genus Claims in Amgen Oral Arguments